Outpatient Continuous Intravenous Interleukin-2 or Subcutaneous, Polyethylene Glycol—Modified Interleukin-2 in Human Immunodeficiency Virus—Infected Patients: A Randomized, Controlled, Multicenter Study
Gespeichert in:
Verfasser / Beitragende:
[Andrew Carr, Sean Emery, Andrew Lloyd, Jennifer Hoy, Roger Garsia, Martyn French, Graeme Stewart, Gwendolyn Fyfe, David A. Cooper]
Ort, Verlag, Jahr:
1998
Enthalten in:
The Journal of Infectious Diseases, 178/4(1998-10), 992-999
Format:
Artikel (online)
Online Zugang: